NEW YORK (GenomeWeb) – Pacific Biosciences and genomics analysis company Bluebee have partnered to develop a de novo assembly pipeline that combines the firm's respective technologies.
They plan to integrate PacBio's de novo assembly pipeline for its single-molecule sequencing platform and Bluebee's cloud-based analysis platform. Netherlands-based Bluebee offers a private, cloud-based genomics analysis platform, designed to work with confidential sample information, meeting security and regulatory standards in the US, the UK, Europe, and Canada.
"The end-to-end solution integrates downstream data analysis in Bluebee's high-security and regulatory-compliant compute centers for PacBio customers around the world," Kevin Corcoran, senior vice president of market development for PacBio, said in a statement.
The solution will be customizable — users can adjust parameters within the platform and optimize it for their specific use cases. Bluebee CEO Hans Cobben further noted that the solution will "address the data analysis burden" of many users.